← Back to Clinical Trials
Recruiting NCT06588543

NCT06588543 Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06588543
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Intracranial Aneurysm
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2024-08-13
Primary Completion 2030-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Endovascular treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2024-08-13 with a primary completion date of 2030-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Endovascular procedures for treating brain aneurysms and arteriovenous malformations (AVMs) are becoming increasingly popular due to their less invasive nature and lower risk of complications. However, they still face challenges such as difficult catheter navigation and incomplete embolization. This study aims to improve the efficiency and safety of endovascular procedures by developing new preoperative planning methodologies. These methodologies involve mapping the cerebral vasculature and creating computational fluid dynamics (CFD) and artificial intelligence (AI) models to simulate blood flow. By using these models, interventional radiologists can better plan catheter navigation and predict embolization outcomes. This could lead to faster, more accurate procedures with reduced radiation exposure for patients.

Eligibility Criteria

Inclusion Criteria: * Subjects who are diagnosed with aneurysm or arteriovenous malformation * Subjects who are treated (or will be treated) with endovascular embolization and/or arteriovenous coiling * During and before/after the subject's intervention, medical images (MRI, 3D rotational angiography, DSA) were collected of the cerebral arterial vascular tree (which can be used to develop patient-specific models), including catheter location and use of contrast fluid to visualize the cerebral to make the arterial tree more visible. Exclusion Criteria: -Procedures during which no imaging was performed

Contact & Investigator

Central Contact

Peter Vanlangenhove, Prof. Dr.

✉ peter.vanlangenhove@uzgent.be

📞 +32 9 3323112

Frequently Asked Questions

Who can join the NCT06588543 clinical trial?

This trial is open to participants of all sexes, studying Intracranial Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06588543 currently recruiting?

Yes, NCT06588543 is actively recruiting participants. Contact the research team at peter.vanlangenhove@uzgent.be for enrollment information.

Where is the NCT06588543 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT06588543 clinical trial?

NCT06588543 is sponsored by University Hospital, Ghent. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology